Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

BACKGROUND: Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the therapeutic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Biosci
Main Authors: Zhou, Song, Qiao, Yu-ming, Liu, Yong-guang, Liu, Ding, Hu, Jian-min, Liao, Jun, Li, Min, Guo, Ying, Fan, Li-pei, Li, Liu-Yang, Zhao, Ming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667799/
https://ncbi.nlm.nih.gov/pubmed/33292452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00492-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados